Acoramidis Stabilizes or Improves NYHA Class at Month 30 to a Greater Extent Than Placebo in Patients With ATTR-CM: Results From the ATTRibute-CM Study

Kevin M. Alexander, Richard K. Cheng, Justin L. Grodin, Michel G. Khouri, Richard Wright, Mathew S. Maurer, Daniel P. Judge, Jing Du, Suresh Siddhanti, Jean-François Tamby, Leonid Katz, Jonathan C. Fox, and Julian D. Gillmore

Click the link below to download a PDF copy of this poster.

Alexander KM, et al. Presented at the 74th Annual Scientific Session of the American College of Cardiology, March 29–31, 2025, in Chicago, IL.